Reshape healthcare by leveraging our proprietary technology which regenerates damaged tissues and restores function, leading to longer, healthier lives and a future where age and injury-related decline are no longer inevitable.
The Moviglia Method is a revolutionary regenerative and rejuvenative medicine approach that integrates autologous mesenchymal stem cells (MSCs) from adipose tissue, lymphocytes, and tissue-specific peptides in a proprietary process to address various pathologies, focusing on injury and age-related diseases. Using personalized cells, this methodology offers guided differentiation and multifactorial therapeutic effects.The cell treatment addresses a broad market, including cardiovascular, respiratory, central nervous system, endocrine, musculoskeletal, integumentary, urinary, reproductive, and immune system conditions. Unique elements include cell preparation processes, lymphocyte activation, co-culture techniques, and treatment protocols.
The Moviglia Method integrates mesenchymal stem cells (MSCs), lymphocytes, and tissue-specific peptides in a proprietary process to address various pathologies, focusing on injury and age-related disease. The methodology represents a novel convergence of stem cell biology, immunology, and regenerative medicine.
MSCs are multipotent stromal cells that can differentiate into various cell types, including
osteoblasts, chondrocytes, myocytes, and adipocytes.
Origin and Isolation: In this protocol, MSCs are derived from autologous adipose
tissue, which is obtained through lipoaspiration followed by enzymatic digestion and
centrifugation to isolate the stromal vascular fraction.
Ex vivo Expansion: The
isolated MSCs undergo controlled
expansion in vitro.
Properties: MSCs are known for their immunomodulatory
properties, trophic factor secretion, and ability to home to sites of injury or
inflammation.
Lymphocytes, specifically T lymphocytes, are key effectors of the adaptive immune
system.
Role in Treatment: They serve as biological guides for the MSCs through
paracrine signaling and direct cell-cell interactions.
Activation Process: The
lymphocytes undergo ex vivo activation using tissue-specific peptides.
The peptides used are short amino acid sequences derived from proteins specific to the
target tissue.
Function: These peptides serve as antigenic stimuli for the
lymphocytes, inducing activation and conferring tissue-specific homing
properties.
Selection Criteria: The peptides are selected based on their ability
to induce a robust T-cell response without triggering autoimmunity.
The treatment modality has applications in various pathological conditions:
Conditions characterized by tissue degeneration and chronic inflammation, such as osteoarthritis or neurodegenerative disorders.
Potential for application in wound healing, organ repair, or post-injury recovery, including paralysis.
The immunomodulatory properties of MSCs, combined with the tolerogenic effects of activated autologous T cells, address conditions like multiple sclerosis and rheumatoid arthritis.
Our Therapy offers a range of benefits, including its minimally invasive nature, rapid recovery time, and potential to support the body’s natural healing processes. By utilizing the patient’s own regenerative cells, this treatment promotes tissue repair and may help reduce pain and inflammation in the affected joint.
Say goodbye to joint discomfort and hello to renewed mobility with Moviglia Method. Our experienced team is ready to guide you every step of the way, helping you achieve lasting relief and a better quality of life.
Default linked.
+54 11 4090 8008